Form 4: Axsome Therapeutics COO Mark Jacobson Exercises and Sells Stock Options
SEC Form 4
Mark Jacobson, Chief Operating Officer of Axsome Therapeutics, exercised stock options and sold a portion of the underlying shares to cover tax obligations.
Summary
- On May 29, 2024, Mark Jacobson, the Chief Operating Officer of Axsome Therapeutics, exercised stock options for 13,693 shares of common stock at an exercise price of $1.30.
- Following the exercise, Jacobson sold 7,910 shares at a weighted average price of $74.3127, with prices ranging from $73.99 to $74.52.
- The sale was executed to cover tax withholding obligations and costs associated with the option exercise.
- After these transactions, Jacobson beneficially owns 5,783 shares of Axsome Therapeutics common stock.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of insider trading activity, specifically the exercise of stock options and subsequent sale of shares to cover tax obligations. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
This is a routine disclosure of insider transactions. It is common for executives to exercise stock options and sell a portion of the shares to cover taxes.
Key Dates
| Date | Description |
|---|---|
| 08/15/2015 | Date stock options became exercisable |
| 06/18/2024 | Expiration date of stock options |
| 05/29/2024 | Date of stock option exercise and subsequent sale of shares |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.